Delayed treatment with tumor necrosis factor inhibitors in incomplete responders to synthetic disease-modifying anti-rheumatic drugs shows an excellent effect in patients with very early rheumatoid arthritis with poor prognosis factors.

MLA

Kita, Junko, et al. “Delayed Treatment with Tumor Necrosis Factor Inhibitors in Incomplete Responders to Synthetic Disease-Modifying Anti-Rheumatic Drugs Shows an Excellent Effect in Patients with Very Early Rheumatoid Arthritis with Poor Prognosis Factors.” Modern Rheumatology, vol. 22, no. 2, Apr. 2012, pp. 195–201. EBSCOhost, https://doi.org/10.1007/s10165-011-0511-y.

APA

Kita, J., Tamai, M., Arima, K., Nakashima, Y., Suzuki, T., Kawashiri, S., Okada, A., Koga, T., Yamasaki, S., Nakamura, H., Origuchi, T., Aramaki, T., Nakashima, M., Fujikawa, K., Tsukada, T., Ida, H., Aoyagi, K., Uetani, M., Eguchi, K., & Kawakami, A. (2012). Delayed treatment with tumor necrosis factor inhibitors in incomplete responders to synthetic disease-modifying anti-rheumatic drugs shows an excellent effect in patients with very early rheumatoid arthritis with poor prognosis factors. Modern Rheumatology, 22(2), 195–201. https://doi.org/10.1007/s10165-011-0511-y

Chicago

Kita, Junko, Mami Tamai, Kazuhiko Arima, Yoshikazu Nakashima, Takahisa Suzuki, Shin-ya Kawashiri, Akitomo Okada, et al. 2012. “Delayed Treatment with Tumor Necrosis Factor Inhibitors in Incomplete Responders to Synthetic Disease-Modifying Anti-Rheumatic Drugs Shows an Excellent Effect in Patients with Very Early Rheumatoid Arthritis with Poor Prognosis Factors.” Modern Rheumatology 22 (2): 195–201. doi:10.1007/s10165-011-0511-y.